tanshinone has been researched along with gsk-2816126 in 1 studies
Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (gsk-2816126) | Trials (gsk-2816126) | Recent Studies (post-2010) (gsk-2816126) |
---|---|---|---|---|---|
1,445 | 10 | 1,033 | 98 | 1 | 96 |
Protein | Taxonomy | tanshinone (IC50) | gsk-2816126 (IC50) |
---|---|---|---|
Polycomb protein EED | Homo sapiens (human) | 0.016 | |
Polycomb protein SUZ12 | Homo sapiens (human) | 0.016 | |
Histone-lysine N-methyltransferase EZH2 | Homo sapiens (human) | 0.035 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Byun, BJ; Chae, CH; Cho, H; Choi, G; Kim, HY; Lee, JY; Park, WK; Ryu, SY; Woo, J | 1 |
1 other study(ies) available for tanshinone and gsk-2816126
Article | Year |
---|---|
Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors.
Topics: Abietanes; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Molecular Conformation; Polycomb Repressive Complex 2; Structure-Activity Relationship | 2014 |